{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:16:59Z","timestamp":1790799419581,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3UG1DA015831-18S7"],"award-info":[{"award-number":["3UG1DA015831-18S7"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cct.2021.106359","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T15:36:45Z","timestamp":1616081805000},"page":"106359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation"],"prefix":"10.1016","volume":"104","author":[{"given":"Gail","family":"D'Onofrio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn F.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Andrew","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Coupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Pantalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia H.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shara H.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"DeVogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Huntley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cct.2021.106359_bb0005","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cct.2021.106359_bb0010","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/add.13900","article-title":"Cost-effectiveness of emergency department-initiated treatment for opioid dependence","volume":"112","author":"Busch","year":"2017","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.cct.2021.106359_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21209","article-title":"Trends in the use of buprenorphine in US emergency departments, 2002\u20132017","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"26","key":"10.1016\/j.cct.2021.106359_bb0020","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMp1811988","article-title":"Emergency departments-a 24\/7\/365 option for combating the opioid crisis","volume":"379","author":"D\u2019Onofrio","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cct.2021.106359_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department\u2013initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.cct.2021.106359_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implement. Sci."},{"issue":"6","key":"10.1016\/j.cct.2021.106359_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamainternmed.2018.1052","article-title":"Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial","volume":"178","author":"Lofwall","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"9","key":"10.1016\/j.cct.2021.106359_bb0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamapsychiatry.2017.1874","article-title":"Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial","volume":"74","author":"Walsh","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.cct.2021.106359_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ADM.0000000000000059","article-title":"Unobserved \u201chome\u201d induction onto buprenorphine","volume":"8","author":"Lee","year":"2014","journal-title":"J. Addict. Med."},{"issue":"5","key":"10.1016\/j.cct.2021.106359_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ADM.0000000000000060","article-title":"Clinical case conference: unobserved \u201chome\u201d induction onto buprenorphine","volume":"8","author":"Lee","year":"2014","journal-title":"J. Addict. Med."},{"issue":"3","key":"10.1016\/j.cct.2021.106359_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med. Care"},{"issue":"3","key":"10.1016\/j.cct.2021.106359_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.cct.2021.106359_bb0075","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","article-title":"The RE-AIM framework: a systematic review of use over time","volume":"103","author":"Gaglio","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.cct.2021.106359_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.cct.2021.106359_bb0085","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1016\/j.cct.2021.106359_bb0090","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","article-title":"The RE-AIM framework: a systematic review of use over time","volume":"103","author":"Gaglio","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.cct.2021.106359_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00952998908993411","article-title":"Informed consent, deception, and the use of disguised alcohol questionnaires","volume":"15","author":"Fleming","year":"1989","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.cct.2021.106359_bb0100","first-page":"81","article-title":"A three-sample test of a masked alcohol screening questionnaire","volume":"26","author":"Fleming","year":"1991","journal-title":"Alcohol Alcohol."},{"issue":"2","key":"10.1016\/j.cct.2021.106359_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"Buprenorphine pharmacology review: update on transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"J. Addict. Med."},{"issue":"2\u20133","key":"10.1016\/j.cct.2021.106359_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2021.106359_bb0115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0006-3223(96)00266-1","article-title":"Buprenorphine and naloxone interactions in methadone maintenance patients","volume":"41","author":"Mendelson","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2021.106359_bb0120","article-title":"National practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"66","author":"Comer","year":"2015","journal-title":"Am. Soc. Addicit. Med."},{"key":"10.1016\/j.cct.2021.106359_bb0125","series-title":"Measuring Alcohol Consumption: Psychosocial and Biological Methods","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported alcohol consumption","author":"Sobel","year":"1992"},{"key":"10.1016\/j.cct.2021.106359_bb0130","series-title":"Treatment Service Review (TSR) Philadelphia: The Center for Studies in Addiction","author":"McLellan","year":"1989"},{"issue":"9","key":"10.1016\/j.cct.2021.106359_bb0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.cct.2021.106359_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.cct.2021.106359_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/add.14799","article-title":"Factor structure, internal reliability and construct validity of the methadone maintenance treatment stigma mechanisms scale (MMT-SMS)","volume":"115","author":"Smith","year":"2020","journal-title":"Addiction."},{"key":"10.1016\/j.cct.2021.106359_bb0150","author":"HealthMeasures"},{"key":"10.1016\/j.cct.2021.106359_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/SAR.S38902","article-title":"The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction","volume":"3","author":"Ling","year":"2012","journal-title":"Subst. Abus. Rehabil."},{"key":"10.1016\/j.cct.2021.106359_bb0160","series-title":"The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions","author":"Mee-Lee","year":"2013"},{"issue":"3","key":"10.1016\/j.cct.2021.106359_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.cct.2021.106359_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ejp.1305","article-title":"The adjective rating scale for withdrawal: validation of its ability to assess severity of prescription opioid misuse","volume":"23","author":"Coloma-Carmona","year":"2019","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.cct.2021.106359_bb0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02189980","article-title":"Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients","volume":"240","author":"Gr\u00fcnberger","year":"1990","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.cct.2021.106359_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/01621459.1995.10476493","article-title":"Analysis of semi-parametric regression models for repeated outcomes in the presence of missing data","volume":"90","author":"Robins","year":"1995","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cct.2021.106359_bb0185","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.cct.2021.106359_bb0190","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2017"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:53:56Z","timestamp":1761555236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714421000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"alternative-id":["S1551714421000951"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2021.106359","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2021.106359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106359"}}